Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix to Receive $25M in Settlement with Insurance Firm

NEW YORK (GenomeWeb News) – CombiMatrix disclosed in a filing with US Securities and Exchange Commission today that it has inked a settlement agreement with National Union Fire Insurance Company, under which CombiMatrix will receive $25 million.

The settlement ends a legal battle that began more than two years ago when CombiMatrix filed a suit claiming that the insurance firm had refused to defend and indemnify CombiMatrix under its director and officer’s insurance policy. In May 2008, the US District Court for the Central District of California entered a final judgment in favor of CombiMatrix for $35.7 million.

Oral arguments before an appeals court were scheduled to be heard next week. However, the settlement will end the case.

National Union has until Feb. 12 to pay the $25 million to settle the dispute.

Settlement of the suit also could make it easier for CombiMatrix to find the "strategic options" it has sought since September with the help of financial advisers RW Baird.

During the firm's third-quarter conference call in November, President and CEO Amit Kumar said that the firm has contacted a number of undisclosed companies about options.

"These companies do not fit a single mold – they include both large cap companies and companies in the middle market, as well as financial organizations that have expressed an interest in getting into this space and are seeking a platform," Kumar said. "Some companies appear interested in acquiring our whole company, while others seen interested in components that are a strategic fit for them."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.